SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-19-038634
Filing Date
2019-08-08
Accepted
2019-08-08 17:26:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tv527197_424b5.htm 424B5 293113
2 GRAPHIC lg_titan-pharma.jpg GRAPHIC 24117
  Complete submission text file 0001144204-19-038634.txt   327489
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230742 | Film No.: 191010710
SIC: 2836 Biological Products, (No Diagnostic Substances)